Cargando…

Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters

OBJECTIVES: To determine whether the CKD-516 produces a significant change in vascular and metabolic parameters in PET/MRI MATERIALS AND METHODS: With institutional Animal Care and Use Committee approval, 18 VX2 carcinoma tumors implanted in bilateral back muscles of 9 rabbits were evaluated. Serial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Su Yeon, Goo, Jin Mo, Lee, Kyung Hee, Ha, Seunggyun, Paeng, Jin Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811032/ https://www.ncbi.nlm.nih.gov/pubmed/29438381 http://dx.doi.org/10.1371/journal.pone.0192706

Ejemplares similares

Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors
por: Joo, Ijin, et al.
Publicado: (2014)

Phase I Study of CKD-516, a Novel Vascular Disrupting Agent, in Patients with Advanced Solid Tumors
por: Oh, Do-Youn, et al.
Publicado: (2016)

Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors
por: Kim, Hark Kyun, et al.
Publicado: (2020)

Pictorial Imaging-Histopathology Correlation in a Rabbit with Hepatic VX2 Tumor Treated by Transarterial Vascular Disrupting Agent Administration
por: He, Jintong, et al.
Publicado: (2020)

Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models
por: Shao, Haibo, et al.
Publicado: (2015)

An improved biopsy technique for rabbits with VX2 bone tumors
por: Cao, Haiying, et al.
Publicado: (2018)

The Characteristics of Vascular Growth in VX2 Tumor Measured by MRI and Micro-CT
por: Qi, X.-L., et al.
Publicado: (2012)

Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma
por: Kim, Min-Young, et al.
Publicado: (2020)

Effectiveness of ozonated saline in the treatment of VX2 tumors in rabbits
por: Ma, Qing, et al.
Publicado: (2019)

Establishment of a modified percutaneous CT-guided paraspinal intramuscular VX-2 squamous cell carcinoma dual tumor model in rabbits
por: Meng, Liangliang, et al.
Publicado: (2021)

Precision of quantitative parameters of (18)F-FDG PET/CT in a rabbit VX2 tumor model
por: Guo, Bin, et al.
Publicado: (2023)

Application of modified closed biopsy in rabbit model of VX2-transplanted bone tumor
por: Bai, Lei Peng, et al.
Publicado: (2021)

FDG-PET for Evaluating the Antitumor Effect of Intraarterial 3-Bromopyruvate Administration in a Rabbit VX2 Liver Tumor Model
por: Park, Hee Sun, et al.
Publicado: (2007)

Percutaneous microwave coagulation for eradication of VX2 tumors subcutaneously in rabbits
por: Zhou, Wenbin, et al.
Publicado: (2012)

Feasibility of hyperspectral analysis for discrimination of rabbit liver VX2 tumor
por: Duan, Feng, et al.
Publicado: (2019)

Comparison of Endoscopic Submuscosal Implantation vs. Surgical Intramuscular Implantation of VX2 Fragments for Establishing a Rabbit Esophageal Tumor Model for Mimicking Human Esophageal Squamous Carcinoma
por: Huang, Jin, et al.
Publicado: (2014)

Enhancement Effect of Microbubble-Enhanced Ultrasound in Microwave Ablation in Rabbit VX2 Liver Tumors
por: Xiao, Shuyi, et al.
Publicado: (2020)

A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery
por: Zou, Yu, et al.
Publicado: (2016)

Comparing CT perfusion with oxygen partial pressure in a rabbit VX2 soft-tissue tumor model
por: Sun, Chang-Jin, et al.
Publicado: (2014)

Doxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor
por: Meng, Mingming, et al.
Publicado: (2016)

Suppression of Rabbit VX‐2 Subcutaneous Tumor Growth by Gadolinium Neutron Capture Therapy
por: Akine, Yasuyuki, et al.
Publicado: (1993)

Rabbit VX2 lung tumor models can form early nodal metastases
por: Gregor, Alexander, et al.
Publicado: (2019)

Effect of Ultrasound Combined With Microbubble Therapy on Interstitial Fluid Pressure and VX2 Tumor Structure in Rabbit
por: Zhang, Qianyun, et al.
Publicado: (2019)

Disruption of Vascular Barriers in Tumors and in the Brain
por: McDannold, Nathan
Publicado: (2015)

No-Touch Radiofrequency Ablation of VX2 Hepatic Tumors In Vivo in Rabbits: A Proof of Concept Study
por: Kim, Tae-Hyung, et al.
Publicado: (2018)

The correlation between multimodal radiomics and pathology about thermal ablation lesion of rabbit lung VX2 tumor
por: Chen, Jin, et al.
Publicado: (2022)

Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics
por: Pascale, Florentina, et al.
Publicado: (2022)

Application of Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost Techniques to Prepare “Safe Margin” in the Rabbit VX2 Limb Tumor Model
por: Wang, Chong-Wen, et al.
Publicado: (2015)

Chloroquine Promotes the Anticancer Effect of TACE in a Rabbit VX2 Liver Tumor Model
por: Gao, Lu, et al.
Publicado: (2013)

Metabolomic Analysis of Liver Tissue from the VX2 Rabbit Model of Secondary Liver Tumors
por: Ibarra, R., et al.
Publicado: (2014)

Percutaneous Ultrasound Guided Implantation of VX2 for Creation of a Rabbit Hepatic Tumor Model
por: White, Sarah B., et al.
Publicado: (2015)

Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model
por: van Breugel, Johanna Maria Mijntje, et al.
Publicado: (2019)

Ultrasound-Guided Percutaneous Ethanol-Paclitaxel Combined Therapy for Rabbit VX2 Liver Tumors
por: Chen, Li, et al.
Publicado: (2021)

Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption
por: Hong, Sheng, et al.
Publicado: (2020)

Multiparametric Monitoring of Early Response to Antiangiogenic Therapy: A Sequential Perfusion CT and PET/CT Study in a Rabbit VX2 Tumor Model
por: Kim, Jung Im, et al.
Publicado: (2014)

Cellular Imaging Using Equivalent Cross-Relaxation Rate Technique in Rabbit VX-2 Tumor Model
por: Nishiofuku, Hideyuki, et al.
Publicado: (2011)

Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits
por: Huang, Yong-Wen, et al.
Publicado: (2015)

Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor
por: Zhong, Genshen, et al.
Publicado: (2015)

Impact of particle size of multivesicular liposomes on the embolic and therapeutic effects in rabbit VX2 liver tumor
por: Tang, Hailing, et al.
Publicado: (2023)

Efficacy of transcatheter arterial chemoembolization combined with sorafenib in inhibiting tumor angiogenesis in a rabbit VX2 liver cancer model
por: Li, WeiZhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_esbacrj5300qlo1lvivpcl54i7